Skip to main content
MedVellum
QuestionsVideosPricing

MedVellum

Fellowship exam preparation across every specialty: source-verified topics, questions in every format, and videos.

Product

  • Specialties
  • Questions
  • Videos
  • Exam tools
  • Pricing

Verification & policy

  • Verified register
  • Editorial policy
  • Privacy
  • Terms

Account

  • Sign in
  • Create account
  • Dashboard
  • Account & billing

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

llms.txtPsychiatry LLM catalogSitemap

Anaes TopicsApplied cardiovascular & respiratory physiology

Anaes · Applied cardiovascular & respiratory physiology

Oxygen cascade & hypoxic pulmonary vasoconstriction

Also known as Oxygen cascade · Alveolar gas equation · Alveolar oxygen · Hypoxic pulmonary vasoconstriction · HPV · One-lung ventilation

Oxygen steps down in partial pressure at each stage from the dry inspired air to the mitochondrion — the oxygen cascade — and the lung matches blood flow to that oxygen by a mechanism unique to the pulmonary circulation: hypoxic pulmonary vasoconstriction. The framework rests on five exam-critical ideas: the oxygen cascade falls from about 159 mmHg in dry inspired air at sea level, through 149 in humidified tracheal air, about 100 in alveolar gas, about 95 in arterial blood, about 40 in capillaries, to about 1 to 3 mmHg in the mitochondria; the alveolar gas equation (PAO2 equals FiO2 times the pressure of Patm minus PH2O minus PaCO2 over the respiratory quotient) gives the alveolar oxygen that sets the top of the arterial step; the alveolar-to-arterial difference is normally small (under about 15 mmHg breathing air) and rises with shunt, mismatch and diffusion impairment; hypoxic pulmonary vasoconstriction constricts pulmonary arterioles in response to ALVEOLAR (not mixed venous) hypoxia, diverting perfusion to better-ventilated lung and so defending V/Q matching; and HPV is impaired by volatile anaesthetics, systemic vasodilators and a low systemic vascular resistance, which is the mechanism of hypoxaemia during one-lung ventilation. Built on the alveolar-gas-equation review (Heymer 2026), the lung-isolation study (Brenn 2024), the microRNA-hypoxic-pulmonary-hypertension review (Ma 2026), the high-altitude cardiovascular review (Chacon-Diaz 2026), the respiratory-rate-and-ventilatory-efficiency study (Jung 2026), and the airway-pressure-release-ventilation gas-exchange recommendations (Nieman 2026).

high6 referencesUpdated 26 July 20269 min readVerification in progress

Practise this topic

  • 16 MCQs

Your progress

Saved on this device.

Practise this topic16 MCQs with explanations

Target exams

ANZCAFRCAABAEDAICFCAIFCA_SA

Red flags

  • Alveolar-gas-equation correspondence-scope (Heymer metabolic perspective, no abstract; equation/lever framing is textbook teaching, not quantified in [1]) [1]; cascade mmHg steps and RQ numbers are viva teaching, not in [1].
  • Lung-isolation study-exact (132 propensity-matched VBT adolescents, 66 unilateral vs 66 bilateral from 351; PIP 29±5 vs 31±5 p=0.026, TV 246±63 vs 334±101 p<0.001, TV/kg 5.6±1.4 vs 6.9±2, A-a 417±126 vs 485±96 p=0.001, similar ICU with hospital longer by a day) [2].
  • HPH miRNA review-scope (20-24 nt post-transcriptional regulators of vasoconstriction/remodelling/EndMT/inflammation/metabolic reprogramming in COPD/ILD-associated HPH; palliative current care, biomarker/therapeutic prospects) [3]; altitude review-scope (hypobaric hypoxia ± cold/UV with sympathetic + pulmonary vasoconstriction + vascular/ventricular remodelling, Andean >2,500 m, PH/HF/CHD synthesis with gaps) [4].
  • RR-efficiency pilot-exact (n-30, 6 mL/kg, RR 15→33 with primary ≤27; 50% MV RR17→25 cuts PaCO2 by 5.1 mmHg 95%CI 4.2-5.9 less than constant-dead-space predicted; dead space 132→189 mL p<0.001 fraction 0.60→0.65; power +181% complete vs +122% fixed I:E at 27; high-VR decline beyond 21-24) [5].
  • APRV expert-recommendation scope (roundtable Nominal Group position statement, not formal guideline: PHIGH to plateau/peak, THIGH to current RR, PLOW 0, TLOW via PEF x75% termination, titrate to physiology, injurious settings) [6]; HPV inhibitor/enhancer and OLV shunt magnitudes are textbook/protocol, not in [6].
On this page
Study tools

Your progress

Saved on this device.

Practise this topic16 MCQs with explanations

Target exams

ANZCAFRCAABAEDAICFCAIFCA_SA

Red flags

  • Alveolar-gas-equation correspondence-scope (Heymer metabolic perspective, no abstract; equation/lever framing is textbook teaching, not quantified in [1]) [1]; cascade mmHg steps and RQ numbers are viva teaching, not in [1].
  • Lung-isolation study-exact (132 propensity-matched VBT adolescents, 66 unilateral vs 66 bilateral from 351; PIP 29±5 vs 31±5 p=0.026, TV 246±63 vs 334±101 p<0.001, TV/kg 5.6±1.4 vs 6.9±2, A-a 417±126 vs 485±96 p=0.001, similar ICU with hospital longer by a day) [2].
  • HPH miRNA review-scope (20-24 nt post-transcriptional regulators of vasoconstriction/remodelling/EndMT/inflammation/metabolic reprogramming in COPD/ILD-associated HPH; palliative current care, biomarker/therapeutic prospects) [3]; altitude review-scope (hypobaric hypoxia ± cold/UV with sympathetic + pulmonary vasoconstriction + vascular/ventricular remodelling, Andean >2,500 m, PH/HF/CHD synthesis with gaps) [4].
  • RR-efficiency pilot-exact (n-30, 6 mL/kg, RR 15→33 with primary ≤27; 50% MV RR17→25 cuts PaCO2 by 5.1 mmHg 95%CI 4.2-5.9 less than constant-dead-space predicted; dead space 132→189 mL p<0.001 fraction 0.60→0.65; power +181% complete vs +122% fixed I:E at 27; high-VR decline beyond 21-24) [5].
  • APRV expert-recommendation scope (roundtable Nominal Group position statement, not formal guideline: PHIGH to plateau/peak, THIGH to current RR, PLOW 0, TLOW via PEF x75% termination, titrate to physiology, injurious settings) [6]; HPV inhibitor/enhancer and OLV shunt magnitudes are textbook/protocol, not in [6].
The one-line answer

The oxygen cascade traces the stepwise fall from dry inspired air through humidified tracheal gas, alveolar gas, arterial blood, mixed venous blood, to the mitochondrion (mmHg-step teaching — no retrieved abstract gives 159/150/100/95/40/1-3 numbers; [1] is a correspondence with no abstract). The owned anchors are VBT lung-isolation A-a injury-exact [2], HPH-miRNA and altitude review-scopes [3][4], RR-efficiency pilot-exact with dead-space/power costs [5], and APRV expert-recommendation scope [6]. Equation levers (raise FiO2, lower PaCO2) are textbook framing; apply OLV/altitude specifics per local thoracic/aeromedical protocols.[1][2][3][4][5][6]

Meet the patient

A 64-year-old smoker is anaesthetised for a right upper lobectomy. The double-lumen tube is placed, the right lung is deflated, and within minutes the SpO2 drops from 99 to 88 percent on FiO2 1.0. The surgeon is mid-dissection and asks you to fix it. (Teaching vignette — SpO2/FiO2 numbers are illustrative, not from any retrieved abstract.)[2]

This is the oxygen cascade meeting HPV in the theatre. Every desaturation manoeuvre you know — raise FiO2, check tube position, apply CPAP to the non-ventilated lung, PEEP to the ventilated lung, reduce volatile depth — is an intervention on one cascade step or on regional blood flow (management hierarchy per local thoracic protocols; the retrieved lung-isolation anchor is bilateral-isolation A-a injury-exact with higher PIP/TV/A-a in 132 matched VBT adolescents [2]).[2]

Anaesthesia Pro

Continue reading

You have read the opening of this topic. The complete unit — every section and its primary-source references — is part of the Anaesthesia fellowship library.

Sign in to continueSee pricing
References6ShowHide
  1. [1]Heymer J, et al. Alveolar gas equation: a metabolic perspective Intensive Care Med, 2026.PMID 41661294
  2. [2]Brenn BR, et al. A Comparative Evaluation of Unilateral and Bilateral Sequential Lung Isolation for Vertebral Body Tethering: A Retrospective Propensity Matched Analysis Cureus, 2024.PMID 38854196
  3. [3]Ma MR, et al. When MicroRNAs meet hypoxic pulmonary hypertension Biomed Pharmacother, 2026.PMID 42166981
  4. [4]Chacón-Díaz M, Lazo Soldevilla MA, Díaz-Lazo A, et al. The cardiovascular system and high-altitude exposure: from adaptation to disease. Part I Arch Peru Cardiol Cir Cardiovasc, 2026.PMID 42238502
  5. [5]Jung C, et al. Effects of increasing respiratory rate on ventilatory efficiency and mechanical costs during low-tidal-volume ventilation: a prospective physiological pilot study Ann Intensive Care, 2026.PMID 42306311
  6. [6]Nieman GF, et al. Expert recommendations for setting and adjusting airway pressure release ventilation based on clinical experience and basic science evidence Front Med (Lausanne), 2026.PMID 41709908

Test yourself

Practise what you just read

  • 16 MCQs
Anaesthesia Pro

$29/ monthor $279 / year

The complete Anaesthesia library, every exam format, one subscription.

  • Complete library for one chosen specialty
  • Timed MCQ mock exams and spaced review
  • Clinical cases & cross-table vivas
See pricingSign in
PreviousNeuromuscular junction physiologyApplied cardiovascular & respiratory physiologyNextOxygen transport & the dissociation curveApplied cardiovascular & respiratory physiology